AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8946434 — intervention group
Group type: COMPARATOR
Intervention: d,l-fenfluramine HCl 0.5 mg/kg
Number of subjects: 11
Study 8946434 — intervention group
Group type: EXPERIMENTAL
Intervention: d-fenfluramine HCl
Number of subjects: 11
Study 8946434 — intervention group
Group type: EXPERIMENTAL
Intervention: d,l-fenfluramine HCl
Number of subjects: 11
Study 2014928 — intervention group
Group type: COMPARATOR
Intervention: Aqueous BSA solution (10 mg/mL) in a titrated double‐blind, placebo‐controlled bronchial inhalation challenge.
Number of subjects: 1
Study 2014928 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol metered dose inhaler and avoidance of laboratory exposure to BSA.
Number of subjects: 1
Study 6750813 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g oral glucose load
Number of subjects: 85
Study 30935317 — intervention group
Group type: EXPERIMENTAL
Intervention: Microembolic Signals (MES) detection
Number of subjects: 48
Study 30935317 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of MESs
Number of subjects: 48
Study 30935317 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent ischemic events
Number of subjects: 48
Study 30935317 — intervention group
Group type: EXPERIMENTAL
Intervention: High mean flow velocities
Number of subjects: 48
Study 27678151 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation (12g daily for 12 weeks)
Number of subjects: 18
Study 27678151 — intervention group
Group type: COMPARATOR
Intervention: Control group (no BCAA supplementation)
Number of subjects: 18
Study 26448183 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive verbal suggestion (inert capsule said to be effective for reducing physical sensitivity)
Number of subjects: 116
Study 26448183 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive imagery (imagining best possible health)
Number of subjects: 116
Study 26448183 — intervention group
Group type: COMPARATOR
Intervention: Control verbal suggestion (inert capsule said to be effective for reducing physical sensitivity in minority of users)
Number of subjects: 116
Study 26448183 — intervention group
Group type: COMPARATOR
Intervention: Control imagery (imagining a typical day)
Number of subjects: 116
Study 23839537 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted vaccine (ADV)
Number of subjects: 911
Study 23839537 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccine (IDV)
Number of subjects: 911
Study 23839537 — intervention group
Group type: EXPERIMENTAL
Intervention: Subunit vaccine (TIV)
Number of subjects: 911
Study 23839537 — intervention group
Group type: COMPARATOR
Intervention: All vaccines (IDV, ADV, TIV)
Number of subjects: 911
Study 21223356 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-742457 (50 mg) + Risperidone (2 mg)
Number of subjects: 18
Study 21223356 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (2 mg)
Number of subjects: 18
Study 21223356 — intervention group
Group type: COMPARATOR
Intervention: SB-742457 (50 mg)
Number of subjects: 18
Study 21223356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 19164438 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute vertebral artery dissection (VAD)
Number of subjects: 50
Study 19164438 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 17551253 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoietin beta
Number of subjects: 32
Study 17551253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15507864 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose balsalazide (2.25 g/day) plus VSL#3 (3 g/day)
Number of subjects: 90
Study 15507864 — intervention group
Group type: COMPARATOR
Intervention: Medium-dose balsalazide alone
Number of subjects: 90
Study 15507864 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine
Number of subjects: 90
Study 15507864 — intervention group
Group type: EXPERIMENTAL
Intervention: Balsalazide/VSL#3
Number of subjects: 90
Study 15507864 — intervention group
Group type: EXPERIMENTAL
Intervention: Balsalazide with or without VSL#3
Number of subjects: 90
Study 12622761 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release (Entocort) capsules
Number of subjects: 14
Study 12622761 — intervention group
Group type: COMPARATOR
Intervention: Standard budesonide capsules
Number of subjects: 14
Study 10052810 — intervention group
Group type: EXPERIMENTAL
Intervention: Air reduction (AR group)
Number of subjects: 147
Study 10052810 — intervention group
Group type: COMPARATOR
Intervention: Barium enema reduction (BE group)
Number of subjects: 147
Study 10052810 — intervention group
Group type: COMPARATOR
Intervention: Saline reduction under ultrasound guidance (US group)
Number of subjects: 147
Study 8588056 — intervention group
Group type: EXPERIMENTAL
Intervention: buspirone 15 or 20 mg tid
Number of subjects: 43
Study 8588056 — intervention group
Group type: COMPARATOR
Intervention: lorazepam 3 or 4 mg tid
Number of subjects: 43
Study 8588056 — intervention group
Group type: COMPARATOR
Intervention: lorazepam
Number of subjects: 43
Study 8588056 — intervention group
Group type: EXPERIMENTAL
Intervention: buspirone
Number of subjects: 43
Study 1778878 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily amikacin dosing (od)
Number of subjects: 348
Study 1778878 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily amikacin dosing (bd)
Number of subjects: 348
Study 7040494 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 14
Study 7040494 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 14
Study 7040494 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug treatment)
Number of subjects: 14
Study 29864052 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 32
Study 29864052 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS)
Number of subjects: 32
Study 29864052 — intervention group
Group type: COMPARATOR
Intervention: Control (Running only)
Number of subjects: 32
Study 29864052 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (SS, DS, Control)
Number of subjects: 32
Study 30664639 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg fluoxetine
Number of subjects: 0
Study 30664639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29945396 — intervention group
Group type: EXPERIMENTAL
Intervention: modified Buzhong Yiqi decoction combined with pelvic floor muscle exercises-biofeedback-electrostimulation
Number of subjects: 186
Study 29945396 — intervention group
Group type: COMPARATOR
Intervention: pelvic floor muscle exercises-biofeedback-electrostimulation
Number of subjects: 186
Study 27417334 — intervention group
Group type: EXPERIMENTAL
Intervention: Pouring apple juice first
Number of subjects: 0
Study 27417334 — intervention group
Group type: COMPARATOR
Intervention: Pouring water first
Number of subjects: 0
Study 27417334 — intervention group
Group type: EXPERIMENTAL
Intervention: Pouring milk before cereals
Number of subjects: 0
Study 27417334 — intervention group
Group type: COMPARATOR
Intervention: Pouring cereals before milk
Number of subjects: 0
Study 24073841 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 80 mg/day
Number of subjects: 25
Study 24073841 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 120 mg/day
Number of subjects: 25
Study 24073841 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 160 mg/day
Number of subjects: 25
Study 24073841 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone (80-160 mg/day)
Number of subjects: 25
Study 23311171 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiawei Shengdan Louxie Sini Fang
Number of subjects: 0
Study 23311171 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (control)
Number of subjects: 0
Study 20195085 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body compression garment (CG)
Number of subjects: 20
Study 18188749 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive recruitment strategy (telephoning women whose phone numbers were purchased from a marketing firm)
Number of subjects: 0
Study 18188749 — intervention group
Group type: COMPARATOR
Intervention: Reactive recruitment strategies (advertisements, press releases, direct mail, Web placement, health care provider outreach)
Number of subjects: 0
Study 15919639 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral goal to reduce fat intake
Number of subjects: 422
Study 15919639 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral goal to increase fruits and vegetables (F&V) consumed
Number of subjects: 422
Study 15919639 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral goal to increase physical activity (PA)
Number of subjects: 422
Study 12627352 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine therapy
Number of subjects: 794
Study 12627352 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine therapy for up to 4 years
Number of subjects: 794
Study 10487307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 100 mg
Number of subjects: 20
Study 10487307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8865085 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual stimulation with a moving target using rotating prismatic glasses
Number of subjects: 0
Study 8865085 — intervention group
Group type: COMPARATOR
Intervention: Pursuing a luminous target on a stable visual background
Number of subjects: 0
Study 1321194 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium intake at 120 mmol/day for 6 days, followed by 10 mmol/day for 8 days, then 400 mmol/day for 8 days (Greifswald study)
Number of subjects: 78
Study 1321194 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium intake at 10, 200 or 400 mmol/day for 7 days (Indianapolis study)
Number of subjects: 78
Study 6435772 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (new analgesic supplement)
Number of subjects: 0
Study 6435772 — intervention group
Group type: COMPARATOR
Intervention: Traditional anaesthesia with halothane
Number of subjects: 0
Study 29688915 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 109
Study 29688915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 29236238 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-week online guided self-help intervention based on problem-solving therapy
Number of subjects: 89
Study 29236238 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 89
Study 29236238 — intervention group
Group type: COMPARATOR
Intervention: Non-CNS cancer controls
Number of subjects: 89
Study 26896473 — intervention group
Group type: COMPARATOR
Intervention: Tetrahydrobiopterin (BH4) 400 mg single dose
Number of subjects: 33
Study 26896473 — intervention group
Group type: COMPARATOR
Intervention: Tetrahydrobiopterin (BH4) 400 mg once daily for 1 week
Number of subjects: 33
Study 26896473 — intervention group
Group type: COMPARATOR
Intervention: Placebo (acute regimen)
Number of subjects: 33
Study 26896473 — intervention group
Group type: COMPARATOR
Intervention: Placebo (short-term regimen)
Number of subjects: 33
Study 26896473 — intervention group
Group type: COMPARATOR
Intervention: Tetrahydrobiopterin (BH4)
Number of subjects: 33
Study 26896473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 24876957 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg
Number of subjects: 90
Study 24876957 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg and Dexamethasone 8 mg
Number of subjects: 90
Study 24876957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 21553153 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Deviance (PD) peer learning groups
Number of subjects: 50
Study 21553153 — intervention group
Group type: COMPARATOR
Intervention: Control group (students not working in PD peer learning groups)
Number of subjects: 50
Study 20010616 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone treatment for prophylaxis of relative adrenal insufficiency
Number of subjects: 350
Study 20010616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study 20010616 — intervention group
Group type: EXPERIMENTAL
Intervention: High cortisol concentrations
Number of subjects: 350
Study 20010616 — intervention group
Group type: EXPERIMENTAL
Intervention: Low cortisol concentrations
Number of subjects: 350
Study 17950452 — intervention group
Group type: EXPERIMENTAL
Intervention: Training
Number of subjects: 98
Study 16085580 — intervention group
Group type: EXPERIMENTAL
Intervention: Emory Cardiac Tool Box (ECTB)
Number of subjects: 70
Study 16085580 — intervention group
Group type: EXPERIMENTAL
Intervention: 4D-MSPECT
Number of subjects: 70
Study 16085580 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative Gated SPECT (QGS)
Number of subjects: 70
Study 16085580 — intervention group
Group type: COMPARATOR
Intervention: cMRI
Number of subjects: 70
Study 12461263 — intervention group
Group type: EXPERIMENTAL
Intervention: MS-325
Number of subjects: 12
Study 10601936 — intervention group
Group type: EXPERIMENTAL
Intervention: Eutectic mixture of local anesthetic cream (lidocaine and prilocaine)
Number of subjects: 60
Study 10601936 — intervention group
Group type: COMPARATOR
Intervention: Dorsal penile nerve block with lidocaine
Number of subjects: 60
Study 8942887 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal fixation (IF)
Number of subjects: 21
Study 8942887 — intervention group
Group type: COMPARATOR
Intervention: External fixation (EF)
Number of subjects: 21
Study 8354766 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (400 mg/day)
Number of subjects: 115
Study 8354766 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine (150 mg/day)
Number of subjects: 115
Study 3726718 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam (2 grams every 12 hours)
Number of subjects: 42
Study 3726718 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin (80 mg every 8 hours) plus Clindamycin (600 mg every 6 hours)
Number of subjects: 42
Study 3726718 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin plus Clindamycin
Number of subjects: 42
Study 3726718 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 42
Study 29855839 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-model communications training course
Number of subjects: 64
Study 29855839 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 64
Study 27207626 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on asthma measure
Number of subjects: 1814
Study 27207626 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on antihypertensive medications
Number of subjects: 1814
Study 25502058 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention (learning catheter-related self-monitoring and self-management skills during home visits by a study nurse)
Number of subjects: 202
Study 25502058 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 202
Study 22677357 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg daily for 4 weeks)
Number of subjects: 20
Study 22677357 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 20
Study 21718165 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg twice a day (b.i.d) starting 24 h prior to ascent
Number of subjects: 24
Study 21718165 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 24
Study 19339719 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 131746
Study 19339719 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 131746
Study 19339719 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytologic testing
Number of subjects: 131746
Study 19339719 — intervention group
Group type: EXPERIMENTAL
Intervention: VIA
Number of subjects: 131746
Study 16126411 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic compressive stockings (ECS) applied during voluntary contractions
Number of subjects: 9
Study 16126411 — intervention group
Group type: COMPARATOR
Intervention: No elastic compressive stockings (ECS) applied during voluntary contractions
Number of subjects: 9
Study 15331681 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise countermeasure (CM-gr)
Number of subjects: 18
Study 15331681 — intervention group
Group type: COMPARATOR
Intervention: Control group (Co-gr)
Number of subjects: 18
Study 15331681 — intervention group
Group type: EXPERIMENTAL
Intervention: Intolerant subjects
Number of subjects: 18
Study 11784476 — intervention group
Group type: COMPARATOR
Intervention: Ethanol 0 g/kg (placebo)
Number of subjects: 16
Study 11784476 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.35 g/kg
Number of subjects: 16
Study 11784476 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.7 g/kg
Number of subjects: 16
Study 11784476 — intervention group
Group type: COMPARATOR
Intervention: N(2)O 0% (100% O(2), placebo)
Number of subjects: 16
Study 11784476 — intervention group
Group type: EXPERIMENTAL
Intervention: N(2)O 30% (in O(2))
Number of subjects: 16
Study 9808223 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol-rich food (556 retinol equivalents (RE)/d)
Number of subjects: 238
Study 9808223 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit (509 RE/d)
Number of subjects: 238
Study 9808223 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark-green, leafy vegetables and carrots (684 RE/d)
Number of subjects: 238
Study 9808223 — intervention group
Group type: COMPARATOR
Intervention: Low-retinol, low-carotene food (44 RE/d)
Number of subjects: 238
Study 8034835 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse Prevention (RP) intervention
Number of subjects: 212
Study 8034835 — intervention group
Group type: COMPARATOR
Intervention: Social Support (SSP) group discussion intervention
Number of subjects: 212
Study 2661989 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambroxol (30 mg, 2 sachets daily for 10 days)
Number of subjects: 28
Study 2661989 — intervention group
Group type: COMPARATOR
Intervention: Acetylcysteine (200-300 mg, 2-3 sachets daily for 10 days)
Number of subjects: 28
Study 29693035 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy for 10-15 min, three times a week for 10 sessions
Number of subjects: 50
Study 29693035 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 50
Study 29693035 — intervention group
Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 50
Study 27440192 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 week supervised exercise therapy
Number of subjects: 140
Study 27440192 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 140
Study 24913266 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 5706
Study 22484700 — intervention group
Group type: EXPERIMENTAL
Intervention: hilafilcon B silicone hydrogel contact lenses for 8 h
Number of subjects: 15
Study 22484700 — intervention group
Group type: COMPARATOR
Intervention: narafilcon A silicone hydrogel contact lenses for 8 h
Number of subjects: 15
Study 19935409 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin treatment
Number of subjects: 30
Study 18492000 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural exercises for 10 weeks
Number of subjects: 88
Study 18492000 — intervention group
Group type: COMPARATOR
Intervention: Strength and fitness exercises for 10 weeks
Number of subjects: 88
Study 18492000 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 88
Study 15711607 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 50 mg o.d.
Number of subjects: 40
Study 15711607 — intervention group
Group type: COMPARATOR
Intervention: Cyproterone acetate 100 mg t.i.d.
Number of subjects: 40
Study 12680736 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg/70 kg)
Number of subjects: 20
Study 12680736 — intervention group
Group type: EXPERIMENTAL
Intervention: d-Amphetamine (20 mg/70 kg)
Number of subjects: 20
Study 12680736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12680736 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg/70 kg) and d-Amphetamine (20 mg/70 kg) conjointly
Number of subjects: 20
Study 10505587 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg orally)
Number of subjects: 20
Study 10505587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2676253 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 0
Study 2676253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 330291 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomotil
Number of subjects: 83
Study 330291 — intervention group
Group type: COMPARATOR
Intervention: Imodium
Number of subjects: 83
Study 30508780 — intervention group
Group type: EXPERIMENTAL
Intervention: Older children
Number of subjects: 173
Study 30508780 — intervention group
Group type: EXPERIMENTAL
Intervention: Less physical activity
Number of subjects: 173
Study 30508780 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter nap(s)
Number of subjects: 173
Study 30508780 — intervention group
Group type: EXPERIMENTAL
Intervention: Later wake‐up times
Number of subjects: 173
Study 30508780 — intervention group
Group type: EXPERIMENTAL
Intervention: Late bedtimes
Number of subjects: 173
Study 30508780 — intervention group
Group type: EXPERIMENTAL
Intervention: None of the potential correlates
Number of subjects: 173
Study 28185300 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training 2.5 times per week for 3 months
Number of subjects: 41
Study 26367862 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga strengthening program (12 weeks, 3 sessions per week)
Number of subjects: 38
Study 24180235 — intervention group
Group type: EXPERIMENTAL
Intervention: Ma Zi Ren Wan and western medicine placebo
Number of subjects: 0
Study 24180235 — intervention group
Group type: COMPARATOR
Intervention: Senna and Chinese medicine placebo
Number of subjects: 0
Study 24180235 — intervention group
Group type: COMPARATOR
Intervention: Chinese medicine placebo and western medicine placebo
Number of subjects: 0
Study 24180235 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0